T. Kahan

发表

2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed b

A Ross Naylor, Marco Roffi, Thomas Kahan, 2018, European heart journal.

2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Jeroen J. Bax, P. Kirchhof, P. Kolh, 2007, Blood pressure.

Predicting readmissions and cardiovascular events in heart failure patients.

T. Kahan, M. Mejhert, H. Persson, 2006, International journal of cardiology.

2018 ESC/ESH Guidelines for the management of arterial hypertension.

Thomas Kahan, Giuseppe Mancia, Krzysztof Narkiewicz, 2018, European heart journal.

Current antihypertensive drug therapy in 12,436 Swedish patients, 90 years and above, in relation to sex and comorbidity

B. Wettermark, T. Kahan, F. Wallentin, 2019, Blood pressure.

The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden

Thomas Kahan, Björn Wettermark, Gunnar Ljunggren, 2013, European journal of heart failure.

Irbesartan and atenolol improve diastolic function in patients with hypertensive left ventricular hypertrophy

T. Kahan, M. Edner, R. Müller-Brunotte, 2005, Journal of hypertension.

Blood pressure and left ventricular geometric pattern determine diastolic function in hypertensive myocardial hypertrophy

T. Kahan, M. Edner, R. Müller-Brunotte, 2003, Journal of Human Hypertension.

Influence of age and cardiovascular factors on regional pulsed wave Doppler myocardial imaging indices.

T. Kahan, M. Edner, R. Müller-Brunotte, 2000, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

Blood pressure response to renal denervation is correlated with baseline blood pressure variability: a patient-level meta-analysis.

J. Staessen, L. Thijs, M. Burnier, 2018, Journal of hypertension.

Non-invasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: A consensus paper from the European Association of Cardiovascular Imaging (EACVI), the European Society of Cardiology Council on Hypertension, and the European Society of Hypertension (ESH)

G. Mancia, B. Williams, G. de Simone, 2017, European heart journal cardiovascular Imaging.

Usefulness of Collagen Carboxy-Terminal Propeptide and Telopeptide to Predict Disturbances of Long-Term Mortality in Patients ≥60 Years With Heart Failure and Reduced Ejection Fraction.

T. Kahan, Arantxa González, J. Díez, 2017, The American journal of cardiology.

Decisions about antihypertensive treatment should focus on reducing cardiovascular risk

T. Kahan, 2021, The Lancet.

Improved treatment and control of hypertension in Swedish primary care: results from the Swedish primary care cardiovascular database

K. Bengtsson Boström, B. Wettermark, T. Kahan, 2017, Journal of hypertension.

Persistence to antihypertensive drug treatment in Swedish primary healthcare

K. Bengtsson Boström, B. Wettermark, T. Kahan, 2013, European Journal of Clinical Pharmacology.

Pharmacological Prevention of Reperfusion Injury in Acute Myocardial Infarction

P. Hjemdahl, T. Kahan, M. Quintana, 2004, American journal of cardiovascular drugs : drugs, devices, and other interventions.

Neurohormonal activation in heart failure after acute myocardial infarction treated with beta‐receptor antagonists

P. Hjemdahl, T. Kahan, Sven Eriksson, 2002, European journal of heart failure.

Hypertension and cardiac arrhythmias: executive summary of a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardí

G. Lip, G. Boriani, T. Potpara, 2017, European heart journal. Cardiovascular pharmacotherapy.

Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiologí

G. Lip, I. V. Van Gelder, B. Gorenek, 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

ESVM Guideline on peripheral arterial disease

L. Mazzolai, G. Mahé, Ali Chraim, 2019 .

The economic consequences of non‐adherence to lipid‐lowering therapy: results from the Anglo‐Scandinavian‐Cardiac Outcomes Trial

M. Buxton, P. Sever, B. Jönsson, 2010, International journal of clinical practice.

compared to an atenolol-based regimen amlodipine-based regimen is cost-effective Antihypertensive treatment with an Economic Evaluation of ASCOT-BPLA :

M. Buxton, N. Poulter, P. Sever, 2007 .

Economic evaluation of ASCOT-BPLA: antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimen

M. Buxton, N. Poulter, P. Sever, 2007, Heart.

Cost-effectiveness of atorvastatin for the prevention of coronary and stroke events: an economic analysis of the Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).

M. Buxton, N. Poulter, P. Sever, 2005, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

Cost-Effectiveness of Atorvastatin for the Prevention of Coronary and Stroke Events: An Economic Analysis of the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA)

M. Buxton, N. Poulter, P. Sever, 2005 .

Is neonatal phototherapy associated with an increased risk for hospitalized childhood bronchial asthma?

B. Källén, T. Kahan, G. Dahlquist, 2007, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Hypertension and heart failure with preserved ejection fraction: position paper by the European Society of Hypertension

G. Mancia, F. Zannad, S. Kjeldsen, 2021, Journal of hypertension.

Nonadrenergic Sympathetic Vascular Control of the Human Forearm in Hypertension: Possible Involvement of Neuropeptide Y

P. Hjemdahl, T. Kahan, R. Pedrinelli, 1992, Journal of cardiovascular pharmacology.

Left ventricular mass is not related to insulin sensitivity in never-treated primary hypertension

T. Kahan, J. Östergren, K. Malmqvist, 2001, Journal of hypertension.

Regression of Left Ventricular Mass with Captopril and Metoprolol, and the Effects on Glucose and Lipid Metabolism

T. Kahan, J. Östergren, K. Malmqvist, 2001, Blood pressure.

Biomarkers of collagen type I metabolism are related to B-type natriuretic peptide, left ventricular size, and diastolic function in heart failure

T. Kahan, Arantxa González, J. Díez, 2014, Journal of cardiovascular medicine.

Cardiac and vascular structure and function are related to lipid peroxidation and metabolism

L. Lind, T. Kahan, S. Basu, 2002, Lipids.

MASked-unconTrolled hypERtension management based on office BP or on ambulatory blood pressure measurement (MASTER) Study: a randomised controlled trial protocol

G. Parati, G. Mancia, A. Zanchetti, 2018, BMJ Open.

Prevalence of treatment-resistant hypertension and important associated factors-results from the Swedish Primary Care Cardiovascular Database.

B. Wettermark, K. Boström, T. Kahan, 2016, Journal of the American Society of Hypertension : JASH.

Hyperresponders vs. nonresponder patients after renal denervation: do they differ?

J. Staessen, M. Burnier, S. Kjeldsen, 2014, Journal of hypertension.

Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate: an analysis of the ASSOCIATE study.

P. Ponikowski, J. Tardif, T. Kahan, 2013, International journal of cardiology.

Antihypertensive treatment and control according to gender, education, country of birth and psychiatric disorder: the Swedish Primary Care Cardiovascular Database (SPCCD)

B. Wettermark, K. Boström, T. Kahan, 2014, Journal of Human Hypertension.

Regression of left ventricular hypertrophy in human hypertension with irbesartan

C. Held, L. Lind, T. Kahan, 2001, Journal of hypertension.

Hot off the Press: Dark chocolate to treat peripheral artery diseases?

T. Kahan, 2018, Hypertension News.

The importance of myocardial fibrosis in hypertensive heart disease.

T. Kahan, 2012, Journal of hypertension.

Giant congenital aneurysm of the non-coronary sinus of Valsalva

T. Kahan, M. Mejhert, H. Persson, 2002, Heart.

Epidemiology of heart failure in Sweden — a national survey

T. Kahan, M. Mejhert, H. Persson, 2001, European journal of heart failure.

Endothelium-Dependent Vasodilation is Impaired in Apparently Healthy Subjects with a Family History of Myocardial Infarction

L. Lind, T. Kahan, J. Millgård, 2002, Journal of cardiovascular risk.

Heart Failure Events in a Clinical Trial on Arterial Hypertension: New Insights Into the SPRINT Trial

P. Nilsson, T. Kahan, P. Sobieraj, 2021, Hypertension.

The importance of left ventricular geometry in hypertensive heart disease.

T. Kahan, H. Persson, 2015, Journal of hypertension.

Tissue velocity echocardiography shows early improvement in diastolic function with irbesartan and atenolol therapy in patients with hypertensive left ventricular hypertrophy. Results form the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).

T. Kahan, M. Edner, R. Müller-Brunotte, 2006, American journal of hypertension.

Evaluation of various electrocardiographic criteria for left ventricular hypertrophy in patients with stable angina pectoris: influence of using modified limb electrodes.

C. Held, P. Hjemdahl, T. Kahan, 2001, Clinical physiology.

Left Ventricular Hypertrophy is Associated with an Attenuated Endothelium-dependent Vasodilation in Hypertensive Men

L. Lind, T. Kahan, K. Malmqvist, 2000, Blood pressure.

Utility loss and indirect costs following cardiovascular events in hypertensive patients: the ASCOT health economic substudy

M. Buxton, N. Poulter, B. Jönsson, 2007, The European Journal of Health Economics.

Cardiovascular risk factors are not treated to target in hypertensive patients in primary care

T. Kahan, Ingegerd Nieburg, 2010, Blood pressure.

Single nucleotide polymorphisms predict the change in left ventricular mass in response to antihypertensive treatment

H. Melhus, L. Lind, A. Syvänen, 2004, Journal of hypertension.

The impact of diabetes, education and income on mortality and cardiovascular events in hypertensive patients: A cohort study from the Swedish Primary Care Cardiovascular Database (SPCCD)

K. Bengtsson Boström, A. Carlsson, T. Kahan, 2020, PloS one.

Endothelium-dependent vasodilation and structural and functional changes in the cardiovascular system are dependent on age in healthy subjects.

L. Lind, T. Kahan, M. Edner, 1999, Clinical physiology.

The Swedish Primary Care Cardiovascular Database (SPCCD): 74 751 hypertensive primary care patients

K. Bengtsson Boström, B. Wettermark, T. Kahan, 2014, Blood pressure.

Abstract 1349: The Economic Consequences of Non-Adherence to Lipid-Lowering Therapy: Results From the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)

M. Buxton, N. Poulter, P. Sever, 2009 .

24-hour ambulatory blood pressure telemonitoring in patients at risk of atrial fibrillation: results from the TEMPLAR project

Stefano Omboni, T. Kahan, Edoardo Panzeri, 2022, Hypertension Research.

2018 ESC/ESH Guidelines for the management of arterial hypertension.

G. Lip, A. Dominiczak, G. Mancia, 2018, European heart journal.

Inhibition of the renin–angiotensin system does not reduce platelet activity at rest or during stress in hypertension

P. Hjemdahl, J. Schwieler, T. Kahan, 2013, Journal of hypertension.

Drug adherence in treatment resistant and in controlled hypertension—Results from the Swedish Primary Care Cardiovascular Database (SPCCD)

B. Wettermark, K. Boström, T. Kahan, 2018, Pharmacoepidemiology and drug safety.

2018 ESC/ESH Guidelines for the Management of Arterial Hypertension

G. Lip, A. Dominiczak, G. Mancia, 2019, Manual of Hypertension of the European Society of Hypertension.

Medication persistence to antihypertensive drug treatment – a cross-sectional study of attitudes towards hypertension and medication in persistent and non-persistent patients

B. Wettermark, T. Kahan, L. Brandt, 2019, Blood pressure.

ESC Council on hypertension position document on the management of hypertensive emergencies.

G. Lip, A. Cremer, P. Gosse, 2018, European heart journal. Cardiovascular pharmacotherapy.

Fetal growth is associated with first‐trimester maternal vascular function

T. Kahan, C. Iacobaeus, M. Thorsell, 2016, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Strategies to identify patients for antihypertensive treatment

T. Kahan, 2019, The Lancet.

Persistence to antihypertensive drug classes

B. Wettermark, K. Boström, T. Kahan, 2016, Medicine.

Antihypertensive treatment and control in a large primary care population of 21 167 patients

B. Wettermark, T. Kahan, A. Sundström, 2011, Journal of Human Hypertension.

Guest Editorial Challenges in Resistant Hypertension.

T. Kahan, 2016, European cardiology.

Acute and chronic calcium antagonist treatment elevates sympathetic activity in primary hypertension.

P. Hjemdahl, T. Kahan, A. Melcher, 1994, Hypertension.

Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis

A. Sollevi, P. Hjemdahl, T. Kahan, 2003, European Journal of Clinical Pharmacology.

Early neurohormonal effects of trandolapril in patients with left ventricular dysfunction and a recent acute myocardial infarction: a double‐blind, randomized, placebo‐controlled multicentre study

K. Swedberg, T. Kahan, Sven Eriksson, 2001, European journal of heart failure.

Endothelium-dependent vasodilatation in treated and untreated hypertensive subjects.

L. Lind, T. Kahan, K. Malmqvist, 1999, Blood pressure.

A single nucleotide polymorphism in the promoter region of the osteoprotegerin gene is related to intima‐media thickness of the carotid artery in hypertensive patients. The Swedish irbesartan left ventricular hypertrophy investigation vs atenolol (SILVHIA)

H. Melhus, L. Lind, T. Kahan, 2004, Blood pressure.

A single nucleotide polymorphism in the promoter region of the human gene for osteoprotegerin is related to vascular morphology and function.

H. Melhus, L. Lind, T. Kahan, 2002, Biochemical and biophysical research communications.

Use of Self-Reported Computerized Medical History Taking for Acute Chest Pain in the Emergency Department – the Clinical Expert Operating System Chest Pain Danderyd Study (CLEOS-CPDS): Prospective Cohort Study

S. Koch, T. Kahan, C. Sundberg, 2020, Journal of medical Internet research.

Medication Persistence in Hypertension in General Practice

B. Wettermark, T. Kahan, M. Qvarnström, 2018 .

BMC Cardiovascular Disorders BioMed Central

K. Michaëlsson, H. Melhus, L. Lind, 2003 .

B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricular mass in response to antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial

K. Michaëlsson, H. Melhus, L. Lind, 2003, Journal of hypertension.

Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial

H. Melhus, L. Lind, T. Kahan, 2002, Journal of hypertension.

Relationships between left ventricular mass and the renin–angiotensin system, catecholamines, insulin and leptin

T. Kahan, F. Nyström, K. Malmqvist, 2002, Journal of internal medicine.

Nurse-recorded and ambulatory blood pressure predicts treatment-induced reduction of left ventricular hypertrophy equally well in hypertension: results from the Swedish irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA) study

T. Kahan, F. Nyström, K. Malmqvist, 2002, Journal of hypertension.

Adrenaline responsiveness in mild hypertension: no evidence for altered beta-adrenoceptor sensitivity.

P. Hjemdahl, U. de Faire, T. Kahan, 1998, Journal of cardiovascular pharmacology.

Exercise-induced platelet activation in essential hypertension: have we solved the puzzle? Reply.

P. Hjemdahl, J. Schwieler, T. Kahan, 2013, Journal of hypertension.

Soluble intercellular adhesion molecule-1 is related to endothelial vasodilatory function in healthy individuals.

L. Lind, T. Kahan, A. Holmlund, 2002, Atherosclerosis.

A prospective cohort study of self-reported computerised medical history taking for acute chest pain: protocol of the CLEOS-Chest Pain Danderyd Study (CLEOS-CPDS)

S. Koch, T. Kahan, C. Sundberg, 2020, BMJ Open.

S. Koch, T. Kahan, C. Sundberg, 2020 .

Circulatory and sympatho-adrenal responses to stress in borderline and established hypertension.

K. Eliasson, P. Hjemdahl, T. Kahan, 1983, Journal of hypertension.

Cardiac repolarization and its relation to ventricular geometry and rate in reverse remodelling during antihypertensive therapy with irbesartan or atenolol: results from the SILVHIA study

T. Kahan, L. Bergfeldt, M. Edner, 2007, Journal of Human Hypertension.

The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomized trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events. The HOPE study investigators.

Janzen, A. M. Møller, D. Debanne, 1996, The Canadian journal of cardiology.

Skin microvascular reactivity and subendocardial viability ratio in relation to dyslipidemia and signs of insulin resistance in non‐diabetic hypertensive patients

T. Kahan, M. Kalani, A. Jekell, 2021, Microcirculation.

Markers of Inflammation, Endothelial Activation, and Arterial Stiffness in Hypertensive Heart Disease and the Effects of Treatment: Results From the SILVHIA Study

T. Kahan, N. H. Wallén, K. Malmqvist, 2013, Journal of cardiovascular pharmacology.

Converting enzyme inhibition modulates sympathetic neurotransmission in vivo via multiple mechanisms.

P. Hjemdahl, J. Schwieler, T. Kahan, 1993, The American journal of physiology.

Spinal cord stimulation for refractory angina pectoris: a retrospective analysis of efficacy and cost-benefit

T. Kahan, H. Persson, M. Edner, 2004, Coronary artery disease.

Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology : ESH / ESC Task Force for the Management of Arterial Hypertension

G. Lip, A. Dominiczak, G. Mancia, 2019 .

Comparison of actions of irbesartan versus atenolol on cardiac repolarization in hypertensive left ventricular hypertrophy: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation Versus Atenolol (SILVHIA).

T. Kahan, L. Bergfeldt, M. Edner, 2002, The American journal of cardiology.

Soluble cell adhesion molecules in hypertensive concentric left ventricular hypertrophy

C. Held, T. Kahan, H. Wallen, 2002, Journal of hypertension.

primary hypertension Acute and chronic calcium antagonist treatment elevates sympathetic activity in

P. Hjemdahl, T. Kahan, A. Melcher, 2011 .

Infusion of angiotensin II increases fibrinolysis in healthy individuals but not in patients with familial combined hyperlipidemia

T. Kahan, N. H. Wallén, G. Jörneskog, 2016, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Angiotensin II infusion in man is proinflammatory but has no short-term effects on thrombin generation in vivo.

T. Kahan, N. H. Wallén, G. Jörneskog, 2009, Thrombosis research.

Socioeconomic status affects achievement of blood pressure target in hypertension: contemporary results from the Swedish primary care cardiovascular database

T. Kahan, L. Schiöler, K. Manhem, 2021, Scandinavian journal of primary health care.

Delapril/Manidipine

T. Kahan, 2012, Drugs.

Long-term calcium antagonist treatment of human hypertension with mibefradil or amlodipine increases sympathetic nerve activity

P. Hjemdahl, T. Kahan, A. Melcher, 2007, Journal of hypertension.

Atrial fibrillation and biomarkers of myocardial fibrosis in heart failure

T. Kahan, Arantxa González, M. Mejhert, 2014, Scandinavian cardiovascular journal : SCJ.

Pregnancy‐associated plasma protein‐A is positively correlated with first‐trimester skin microvascular reactivity

T. Kahan, C. Iacobaeus, M. Thorsell, 2018, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

The relationship between the plasma concentration of irbesartan and the antihypertensive response is disclosed by an angiotensin II type 1 receptor polymorphism: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs. Atenolol (SILVHIA) Trial.

H. Melhus, L. Lind, A. Syvänen, 2008, American journal of hypertension.

Reply.

T. Kahan, B. Rundqvist, J. Spaak, 2019, Journal of hypertension.

Cardiac structure and function, and ventricular-arterial interaction 11 years following a pregnancy with preeclampsia.

M. Eriksson, T. Kahan, K. Bremme, 2016, Journal of the American Society of Hypertension : JASH.

Reassessment of data on timing peak flow-mediated vasodilatation confirms that endothelial function returns to normal 11 years after preeclampsia

T. Kahan, K. Bremme, E. Östlund, 2015, Hypertension Research.

The influence of long-term ACE inhibitor treatment on circulatory responses to stress in human hypertension.

K. Eliasson, T. Kahan, 1999, American journal of hypertension.

Responses to mental stress and physical provocations before and during long term treatment of hypertensive patients with beta-adrenoceptor blockers or hydrochlorothiazide.

K. Eliasson, P. Hjemdahl, T. Kahan, 1987, British journal of clinical pharmacology.

Altered vascular responses to circulating angiotensin II in familial combined hyperlipidemia

T. Kahan, N. H. Wallén, G. Jörneskog, 2008, Journal of cardiovascular medicine.

Noradrenaline release evoked by a physiological irregular sympathetic discharge pattern is modulated by prejunctional α‐ and β‐adrenoceptors in vivo

B. Wallin, P. Hjemdahl, J. Schwieler, 1988 .

Aortic stiffness and aortic-brachial stiffness mismatch as markers of renal dysfunction in hypertension

T. Kahan, S. Jacobson, J. Spaak, 2022, Blood pressure.

Cardiac function, myocardial mechano-energetic efficiency, and ventricular–arterial coupling in normal pregnancy

T. Kahan, K. Bremme, C. Iacobaeus, 2017, Journal of hypertension.

Relationship between the overflow of endogenous and radiolabelled noradrenaline from canine blood perfused gracilis muscle.

P. Hjemdahl, T. Kahan, C. Dahlöf, 1984, Acta physiologica Scandinavica.

Gender‐specific association between preproendothelin‐1 genotype and reduction of systolic blood pressure during antihypertensive treatment‐‐‐results from the Swedish irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA)

K. Michaëlsson, H. Melhus, L. Lind, 2004, Clinical cardiology.

Treatment of Hypertensive Left Ventricular Hypertrophy.

P. Nilsson, T. Kahan, A. Jekell, 2019, Current pharmaceutical design.

Myocardial fibrosis and diastolic dysfunction in patients with hypertension: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)

T. Kahan, Arantxa González, J. Díez, 2007, Journal of hypertension.

24-hour ambulatory blood pressure telemonitoring in patients at risk of atrial fibrillation: results from the TEMPLAR project

Stefano Omboni, T. Kahan, Edoardo Panzeri, 2022, Hypertension Research.

Chlorothalidon or hydrochlorothizide for treatment of hypertension?

T. Kahan, 2020, Hypertension News.

The importance of left ventricular hypertrophy in human hypertension.

T. Kahan, 1998, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

Participation of prostaglandins and bradykinin in the effects of angiotensin II and converting enzyme-inhibition on sympathetic neurotransmission in vivo.

P. Hjemdahl, J. Schwieler, T. Kahan, 1994, Acta physiologica Scandinavica.

User experience of self‐reported computerized medical history taking for acute chest pain: The Clinical Expert Operating System Chest Pain Danderyd Study

S. Koch, T. Kahan, C. Sundberg, 2022, Health expectations : an international journal of public participation in health care and health policy.

User Experience of Self-Reported Computerized Medical History Taking for Acute Chest Pain in the Clinical Expert Operating System - Chest Pain Danderyd Study (CLEOS-CPDS): Interview Study Among Patients (Preprint)

S. Koch, T. Kahan, C. Sundberg, 2021 .

ECG monitoring in in-hospital cardiac arrest (IHCA)

Thomas Kahan, Johan Herlitz, Therese Djärv, 2019, Resuscitation.

Possible involvement of neuropeptide Y in sympathetic vascular control of canine skeletal muscle.

P. Hjemdahl, T. Kahan, J. Pernow, 1988, Acta physiologica Scandinavica.

Neuropeptide Y and reserpine‐resistant vasoconstriction evoked by sympathetic nerve stimulation in the dog skeletal muscle

T. Kahan, J. Pernow, J. Lundberg, 1988, British journal of pharmacology.

Influence of the renin-angiotensin system on sympathetic neurotransmission in canine skeletal muscle in vivo

P. Hjemdahl, J. Schwieler, T. Kahan, 1990, Naunyn-Schmiedeberg's Archives of Pharmacology.

Angiotensinogen gene polymorphisms: relationship to blood pressure response to antihypertensive treatment. Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial.

H. Melhus, L. Lind, A. Syvänen, 2004, American journal of hypertension.

Prejunctional α‐Adrenoceptor-Mediated Inhibition of Norepinephrine Release in Blood‐Perfused Skeletal Muscle In Situ

P. Hjemdahl, T. Kahan, C. Dahlöf, 1987, Journal of cardiovascular pharmacology.

arrhythmogenic potential Left ventricular hypertrophy in hypertension: its

T. Kahan, L. Bergfeldt, 2005 .

Treatment with irbesartan or atenolol improves endothelial function in essential hypertension

L. Lind, T. Kahan, J. Millgård, 2001, Journal of hypertension.

Large differences between patients with acute myocardial infarction included in two Swedish health registers

T. Kahan, M. Köster, U. Stenestrand, 2013, Scandinavian journal of public health.

Confirmed association between neonatal phototherapy or neonatal icterus and risk of childhood asthma

B. Källén, T. Kahan, G. Dahlquist, 2010, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Aldosterone synthase (CYP11B2) -344 C/T polymorphism is related to antihypertensive response: result from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial.

H. Melhus, L. Lind, T. Kahan, 2002, American journal of hypertension.

Rate and extent of left ventricular hypertrophy regression: a comparison of angiotensin II blockade with irbesartan and beta-blockade

T. Kahan, M. Edner, C. Hold, 1998 .

Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis, results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study.

A. Sollevi, P. Hjemdahl, T. Kahan, 2003, European journal of clinical pharmacology.

Limited long term effects of a management programme for heart failure

T. Kahan, M. Mejhert, H. Persson, 2004, Heart.

Plasma angiotensins and human forearm circulation: effects of sympatho-adrenal activation.

T. Kahan, J. Nussberger, A. Melcher, 1997, Acta physiologica Scandinavica.

Blood pressure changes after renal denervation at 10 European expert centers

J. Staessen, M. Burnier, S. Kjeldsen, 2013, Journal of Human Hypertension.

Renal nerve stimulation to predict responders to renal denervation

T. Kahan, J. Spaak, Thomas Kahan, 2014, Journal of Human Hypertension.

Fetal and perinatal risk factors for inflammatory bowel disease

B. Källén, T. Kahan, G. Dahlquist, 2006, Acta paediatrica.

Altered Vascular Reactivity to Circulating Angiotensin II in Familial Hypercholesterolemia

T. Kahan, G. Jörneskog, J. Brinck, 2021, Journal of cardiovascular pharmacology.

Management of a Pregnant Woman With Fibromuscular Dysplasia.

A. Dominiczak, J. Staessen, R. Touyz, 2018, Hypertension.

Prejunctional beta 2-adrenoreceptor blockade reduces nerve stimulation evoked release of endogenous noradrenaline in skeletal muscle in situ.

T. Kahan, C. Dahlöf, B. Åblad, 1987, Acta physiologica Scandinavica.

Long-term angiotensin-converting enzyme inhibition with ramipril reduces thrombin generation in human hypertension.

K. Eliasson, T. Kahan, H. Johnsson, 2002, Clinical science.

Influence of acetylcholine, peptides, and other vasodilators on endogenous noradrenaline overflow and vasoconstriction in canine blood perfused gracilis muscle.

P. Hjemdahl, T. Kahan, C. Dahlöf, 1985, Acta physiologica Scandinavica.

Aphasia in acute stroke and relation to outcome

T. Kahan, V. Murray, A. Laska, 2001, Journal of internal medicine.

Influence of angiotensin II, α- and β-adrenoceptors on peripheral noradrenergic neurotransmission in canine gracilis muscle in vivo

P. Hjemdahl, J. Schwieler, T. Kahan, 1992 .

Pre- and postjunctional alpha-adrenoceptor-mediated effects of prazosin, methoxamine and 6-fluoronoradrenaline in blood-perfused canine skeletal muscle in situ.

P. Hjemdahl, T. Kahan, 1987, European journal of pharmacology.

Risk prediction in stable angina pectoris

C. Held, P. Hjemdahl, T. Kahan, 2013, European journal of clinical investigation.

Effects of sympatho-adrenal activation on the finger microcirculation in mild hypertension.

P. Hjemdahl, U. de Faire, T. Kahan, 1992, Journal of human hypertension.

Sex differences in arterial hypertension

G. Parati, A. Maas, G. de Simone, 2022, European heart journal.

Prognostic importance of biomarkers associated with haemostatic, vascular and endothelial disturbances in acute coronary syndrome patients in relation to kidney function.

B. Lindahl, G. Marko‐Varga, M. Rezeli, 2022, International journal of cardiology.

Health economics of prevention of coronary heart disease and vascular events: a cost-effectiveness analysis based on the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)

M. Buxton, N. Poulter, B. Jönsson, 2001, Journal of Human Hypertension.

Facilitation of nerve stimulation evoked noradrenaline overflow by isoprenaline but not by circulating adrenaline in the dog in vivo.

P. Hjemdahl, T. Kahan, C. Dahlöf, 1987, Life sciences.

Covid-19 associated reduction in hypertension-related diagnostic and therapeutic procedures in Excellence Centers of the European Society of Hypertension

P. Gosse, G. Mancia, M. Muiesan, 2022, Blood pressure.

Forearm vasodilator mechanisms during mental stress: possible roles for epinephrine and ANP.

P. Hjemdahl, T. Kahan, P. Bie, 1996, The American journal of physiology.

Reply.

T. Kahan, C. Iacobaeus, M. Thorsell, 2018, Journal of hypertension.

The Impact of the Renin-Angiotensin-Aldosterone System on Inflammation, Coagulation, and Atherothrombotic Complications, and to Aggravated COVID-19

T. Kahan, M. Ekholm, 2021, Frontiers in Pharmacology.

A Randomized Controlled Trial on Very Early Speech and Language Therapy in Acute Stroke Patients with Aphasia

T. Kahan, V. Murray, A. Laska, 2011, Cerebrovascular Diseases Extra.

Design and Methods of a Randomized Controlled Trial on Early Speech and Language Therapy in Patients with Acute Stroke and Aphasia

T. Kahan, V. Murray, A. Laska, 2008, Topics in stroke rehabilitation.

Editor's Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).

Jeroen J. Bax, P. Kolh, I. Simpson, 2018, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

Irbesartan reduces common carotid artery intima‐media thickness in hypertensive patients when compared with atenolol: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) study

C. Held, T. Kahan, K. Malmqvist, 2007, Journal of internal medicine.

Determination of plasma catecholamines by high performance liquid chromatography with electrochemical detection: comparison with a radioenzymatic method.

P. Hjemdahl, T. Kahan, M. Daleskog, 1979, Life sciences.

Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients

H. Melhus, L. Lind, T. Kahan, 2001, Journal of hypertension.

Circulatory effects and pharmacology of clevidipine, a novel ultra short acting and vascular selective calcium antagonist, in hypertensive humans.

J. Schwieler, T. Kahan, H. Ericsson, 1999, Journal of cardiovascular pharmacology.

Nutraceuticals and blood pressure control: a European Society of Hypertension position document.

G. Mancia, G. Grassi, P. van de Borne, 2020, Journal of hypertension.

ECG-monitoring of in-hospital cardiac arrest and factors associated with survival.

J. Engdahl, T. Djärv, T. Kahan, 2020, Resuscitation.

A microarray minisequencing system for pharmacogenetic profiling of antihypertensive drug response.

H. Melhus, L. Lind, A. Syvänen, 2003, Pharmacogenetics.

[2018 ESC/ESH Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)].

Thomas Kahan, Giuseppe Mancia, Krzysztof Narkiewicz, 2018, Giornale italiano di cardiologia.

2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).

V. Aboyans, L. Mazzolai, C. Vlachopoulos, 2018, Revista espanola de cardiologia.

Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases , in collaboration with the European Society for Vascular Surgery ( ESVS ) – Web Addenda

V. Aboyans, L. Mazzolai, C. Vlachopoulos, 2017 .

2018 Practice guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension

Thomas Kahan, Giuseppe Mancia, Stéphane Laurent, 2018, Blood pressure.

[2018 ESC/ESH Guidelines for the management of arterial hypertension].

Thomas Kahan, Giuseppe Mancia, Krzysztof Narkiewicz, 2019, Kardiologia polska.

Influence of sympathetic discharge pattern on norepinephrine and neuropeptide Y release.

B. Wallin, P. Hjemdahl, J. Schwieler, 1989, The American journal of physiology.

Longitudinal study of vascular structure and function during normal pregnancy

T. Kahan, C. Iacobaeus, M. Thorsell, 2017, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Hypertension types defined by clinic and ambulatory blood pressure in 14 143 patients referred to hypertension clinics worldwide. Data from the ARTEMIS study

K. Kario, G. Parati, G. Mancia, 2016, Journal of hypertension.

Safety of digoxin use in patients with hypertensive heart disease and atrial fibrillation.

T. Kahan, 2015, Journal of hypertension.

Haemostatic and inflammatory alterations in familial hypercholesterolaemia, and the impact of angiotensin II infusion

T. Kahan, G. Jörneskog, J. Brinck, 2015, Journal of the renin-angiotensin-aldosterone system : JRAAS.

Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease.

M. Brodmann, T. Kahan, L. Tokgözoğlu, 2021, VASA. Zeitschrift fur Gefasskrankheiten.

Lipid-lowering and anti-thrombotic therapy in patients with peripheral arterial disease: European Atherosclerosis Society/European Society of Vascular Medicine Joint Statement.

M. Brodmann, T. Kahan, L. Tokgözoğlu, 2021, Atherosclerosis.

Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment.

Thomas Kahan, Brian Godman, Niklas Hedberg, 2010, Health policy.

Blood pressure levels and risk of haemorrhagic stroke in patients with atrial fibrillation and oral anticoagulants: results from The Swedish Primary Care Cardiovascular Database of Skaraborg

K. Bengtsson Boström, T. Kahan, L. Schiöler, 2021, Journal of hypertension.

The 2013 ESH/ESC guidelines for the management of arterial hypertension

Helmut Baumgartner, Jens Jordan, Michael Böhm, 2013 .

Beta1‐adrenergic receptor gene polymorphisms and response to Beta1‐adrenergic receptor blockade in patients with essential hypertension

K. Michaëlsson, H. Melhus, L. Lind, 2004, Clinical cardiology.

Elevated blood lipids are uncommon in patients with post-polio syndrome – a cross sectional study

T. Kahan, K. Borg, E. Melin, 2015, BMC Neurology.

Noninvasive cardiovascular imaging for evaluating subclinical target organ damage in hypertensive patients: a consensus article from the European Association of Cardiovascular Imaging, the European Society of Cardiology Council on Hypertension and the European Society of Hypertension*

G. Mancia, B. Williams, G. de Simone, 2017, Journal of hypertension.

Long-Term Effects of Irbesartan and Atenolol on the Renin-Angiotensin-Aldosterone System in Human Primary Hypertension: The Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA)

L. Lind, T. Kahan, F. Nyström, 2003, Journal of cardiovascular pharmacology.

Antihypertensive drug classes and the risk of hip fracture: results from the Swedish primary care cardiovascular database.

D. Mellström, K. Boström, T. Kahan, 2019, Journal of hypertension.

Eligibility for Renal Denervation: Experience at 11 European Expert Centers

A. Dominiczak, B. Gerber, J. Staessen, 2014, Hypertension.

Treatment of mild to moderate hypertension by gender perspective: a systematic review.

T. Kahan, K. Manhem, C. Ljungman, 2009, Journal of women's health.

Efficacy of the If current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial

P. Ponikowski, J. Tardif, T. Kahan, 2009, European heart journal.

Transforming growth factor β1 genotype and change in left ventricular mass during antihypertensive treatment–results from the swedish irbesartan left ventricular hypertrophy investigation versus atenolol (Silvhia)

H. Melhus, L. Lind, A. Syvänen, 2004 .

The CYP2C9 genotype predicts the blood pressure response to irbesartan: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial

H. Melhus, L. Lind, P. Hallberg, 2002, Journal of hypertension.

Mechanisms of exercise‐induced ST‐segment depression in patients without typical angina pectoris

P. Hjemdahl, T. Kahan, G. Sundkvist, 2007, Journal of internal medicine.

Clinical and prognostic properties of standardized and functional aphasia assessments.

A. Bartfai, T. Kahan, V. Murray, 2007, Journal of rehabilitation medicine.

How to best assess quality of drug treatment in patients with heart failure

B. Wettermark, S. Johansson, T. Kahan, 2016, European Journal of Clinical Pharmacology.

Effects of Angiotensin-Converting Enzyme Inhibition and Alpha 1-Adrenergic Receptor Blockade on Inflammation and Hemostasis in Human Hypertension

B. Gigante, T. Kahan, A. Jekell, 2018, Journal of cardiovascular pharmacology.

Normalized endothelial function but sustained cardiovascular risk profile 11 years following a pregnancy complicated by preeclampsia

A. Larsson, M. Eriksson, T. Kahan, 2013, Hypertension Research.

Cardiovascular outcome in treatment-resistant hypertension: results from the Swedish Primary Care Cardiovascular Database (SPCCD)

B. Wettermark, K. Boström, T. Kahan, 2018, Journal of hypertension.

Drug treatment of hypertension in Sweden in relation to sex, age, and comorbidity

Thomas Kahan, Björn Wettermark, B. Wettermark, 2018, Journal of clinical hypertension.

The effects of baroreflex activation therapy on blood pressure and sympathetic function in patients with refractory hypertension: the rationale and design of the Nordic BAT study*

J. Elf, D. Gordin, P. Groop, 2017, Blood pressure.

The effects of alpha 1-adrenoceptor blockade and angiotensin converting enzyme inhibition on central and brachial blood pressure and vascular reactivity: the doxazosin–ramipril study

T. Kahan, M. Kalani, A. Jekell, 2016, Heart and Vessels.

The interrelation of endothelial function and microvascular reactivity in different vascular beds, and risk assessment in hypertension: results from the Doxazosin–ramipril study

T. Kahan, M. Kalani, A. Jekell, 2018, Heart and Vessels.

Determinants of Utility Based on the EuroQol Five-Dimensional Questionnaire in Patients with Chronic Heart Failure and Their Change Over Time: Results from the Swedish Heart Failure Registry.

T. Kahan, U. Dahlström, M. Mejhert, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Effects of exenatide on microvascular reactivity in patients with type 2 diabetes and coronary artery disease: A randomized controlled study

A. Shore, T. Kahan, J. Kuhl, 2020, Microcirculation.

Renal sympathetic denervation in Sweden: a report from the Swedish registry for renal denervation

J. Elf, T. Kahan, B. Andersson, 2018, Journal of hypertension.

The usefulness of a single arm cuff oscillometric method (Arteriograph) to assess changes in central aortic blood pressure and arterial stiffness by antihypertensive treatment: results from the Doxazosin-Ramipril Study

T. Kahan, A. Jekell, 2018, Blood pressure.

Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

G. Parati, T. Lüscher, C. Tsioufis, 2023, European heart journal.

Is left ventricular diastolic function an independent marker of prognosis after acute myocardial infarction?

A. Sollevi, P. Hjemdahl, T. Kahan, 2004, International journal of cardiology.

Systematic Review of Validity Assessments of Framingham Risk Score Results in Health Economic Modelling of Lipid-Modifying Therapies in Europe

T. Kahan, J. Hermansson, 2017, PharmacoEconomics.

T. Kahan, M. Mejhert, H. Persson, 2014, JRSM Cardiovascular Disease.

Left ventricular hypertrophy in hypertension: its arrhythmogenic potential

T. Kahan, L. Bergfeldt, 2005, Heart.

Oscillometrically Measured Aortic Pulse Wave Velocity Reveals Asymptomatic Carotid Atherosclerosis in a Middle-Aged, Apparently Healthy Population

T. Kahan, A. Bikov, A. Cziráki, 2020, BioMed research international.

Peripartum management of hypertension. A position paper of the ESC Council on Hypertension and the European Society of Hypertension.

V. Regitz-Zagrosek, G. Parati, B. Williams, 2019, European heart journal. Cardiovascular pharmacotherapy.

Blood pressure variability: methodological aspects, clinical relevance and practical indications for management - a European Society of Hypertension position paper

K. Kario, G. Parati, G. Mancia, 2023, Journal of hypertension.

Severely impaired microvascular reactivity in diabetic patients with an acute coronary syndrome

T. Kahan, M. Kalani, G. Jörneskog, 2016, Cardiovascular Diabetology.

Prognostic implications of autonomic function assessed by analyses of catecholamines and heart rate variability in stable angina pectoris

C. Held, P. Hjemdahl, M. Ericson, 2002, Heart.

Country of birth and mortality risk in hypertension with and without diabetes: the Swedish primary care cardiovascular database.

K. Bengtsson Boström, A. Carlsson, T. Kahan, 2020, Journal of hypertension.

Cardiovascular and sympatho-adrenal responses to mental stress in primary hypertension.

P. Hjemdahl, T. Kahan, A. Melcher, 1993, Clinical science.

Gender differences in antihypertensive drug treatment: results from the Swedish Primary Care Cardiovascular Database (SPCCD).

Thomas Kahan, Karin Manhem, Linus Schiöler, 2014, Journal of the American Society of Hypertension : JASH.

Low-dose combination of blood pressure-lowering medicines

T. Kahan, 2021, The Lancet.

Long term health care consumption and cost expenditure in systolic heart failure.

T. Kahan, M. Mejhert, H. Persson, 2013, European journal of internal medicine.

Long‐term stability of heart rate variability in chronic stable angina pectoris, and the impact of an acute myocardial infarction

Mats Ericson, Thomas Kahan, P. Hjemdahl, 2009, Clinical physiology and functional imaging.

The cost‐effectiveness of ramipril in the treatment of patients at high risk of cardiovascular events: a Swedish sub‐study to the HOPE study

T. Kahan, T. Kahan, J. Östergren, 2002, Journal of internal medicine.

Highlights from 2022 in EHJ Open

S. Larsson, M. Banach, F. Braunschweig, 2022, European heart journal open.

Use of proteomics to identify biomarkers associated with chronic kidney disease and long‐term outcomes in patients with myocardial infarction

B. Lindahl, M. Evans, G. Marko‐Varga, 2020, Journal of internal medicine.

Long-Term Antidepressant Treatment with Moclobemide for Aphasia in Acute Stroke Patients: A Randomised, Double-Blind, Placebo-Controlled Study

T. Kahan, V. Murray, A. Laska, 2005, Cerebrovascular Diseases.

Prejunctional adrenergic receptors and sympathetic neurotransmission: studies in canine skeletal muscle vasculature in situ.

T. Kahan, 1987, Acta physiologica Scandinavica. Supplementum.

Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide.

T. Kahan, K. Malmqvist, M. Dahl, 2000, American journal of hypertension.

Relation Between Lipid Profile and New-Onset Atrial Fibrillation in Patients With Systemic Hypertension (From the Swedish Primary Care Cardiovascular Database [SPCCD]).

K. Bengtsson Boström, T. Kahan, L. Schiöler, 2018, The American journal of cardiology.

G. Parati, T. Lüscher, C. Tsioufis, 2023, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

The transition from hypertension to hypertensive heart disease and heart failure: the PREFERS Hypertension study

M. Ugander, T. Kahan, C. Linde, 2020, ESC heart failure.

Target blood pressure in patients at high cardiovascular risk

T. Kahan, 2017, The Lancet.

Focus on blood pressure as a major risk factor

T. Kahan, 2014, The Lancet.

Thiazide diuretics and the risk of osteoporotic fractures in hypertensive patients. Results from the Swedish Primary Care Cardiovascular Database

D. Mellström, K. Boström, T. Kahan, 2017, Journal of hypertension.

[PP.LB01.10] PREFERRED DRUG CLASSES TO INITIATE ANTIHYPERTENSIVE TREATMENT IN SWEDISH PRIMARY CARE: RESULTS FROM THE SWEDISH PRIMARY CARE CARDIOVASCULAR DATABASE

B. Wettermark, K. Boström, T. Kahan, 2016 .

Stress‐induced changes in blood pressure and left ventricular function in mild hypertension

P. Hjemdahl, T. Kahan, K. Lindvall, 1991, Clinical cardiology.

Differential Index: A Simple Time Domain Heart Rate Variability Analysis with Prognostic Implications in Stable Angina Pectoris

C. Held, P. Hjemdahl, M. Ericson, 2008, Cardiology.

Differential index, a novel graphical method for measurements of heart rate variability.

C. Held, P. Hjemdahl, M. Ericson, 2005, International journal of cardiology.

Persistence to antihypertensive drug treatment in Swedish primary healthcare

K. Bengtsson Boström, B. Wettermark, T. Kahan, 2013, European Journal of Clinical Pharmacology.

Single nucleotide polymorphisms in the apolipoprotein B and low density lipoprotein receptor genes affect response to antihypertensive treatment

L. Lind, A. Syvänen, T. Kahan, 2004, BMC cardiovascular disorders.

The effects of cardiac events on quality of life and indirect costs

T. Kahan, N. Poulter, P. Svarvar, 2001, Journal of Human Hypertension.

Prediabetes and incident heart failure in hypertensive patients: Results from the Swedish Primary Care Cardiovascular Database.

K. Bengtsson Boström, T. Kahan, P. Hjerpe, 2022, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Platelet activation during exercise is not attenuated by inhibition of the renin angiotensin system: the role of physical activity.

P. Hjemdahl, J. Schwieler, T. Kahan, 2013, Journal of hypertension.

Antihypertensive control and new-onset atrial fibrillation: Results from the Swedish Primary Care Cardiovascular Database (SPCCD)

K. Bengtsson Boström, T. Kahan, L. Schiöler, 2017, European journal of preventive cardiology.

Nurse‐recorded clinic and ambulatory blood pressures correlate equally well with left ventricular mass and carotid intima‐media thickness

T. Kahan, F. Nyström, K. Malmqvist, 2005, Journal of internal medicine.

Sex differences in systolic heart failure in the elderly: the prognostic importance of left ventricular mass in women.

T. Kahan, M. Mejhert, H. Persson, 2008, Journal of women's health.

Recognition of Depression in Aphasic Stroke Patients

T. Kahan, V. Murray, A. Laska, 2007, Cerebrovascular Diseases.

Involvement of neuropeptide Y in sympathetic vascular control of skeletal muscle in vivo

B. Wallin, P. Hjemdahl, J. Schwieler, 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[OP.7A.04] ANTIHYPERTENSIVE DRUGS AND THE RISK OF FEMUR FRACTURE IN HYPERTENSIVE PATIENTS IN SWEDISH PRIMARY HEALTH CARE. RESULTS FROM THE SWEDISH PRIMARY CARE CARDIOVASCULAR DATABASE (SPCCD)

D. Mellström, T. Kahan, L. Schiöler, 2016, Journal of hypertension.

The effects of adenosine as adjuvant therapy in acute myocardial infarction on cardiovascular events. Results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study

A. Sollevi, P. Hjemdahl, T. Kahan, 2001 .

7B.10: THIAZIDE DIURETICS AND FRACTURE-RISK AMONG HYPERTENSIVE PATIENTS. RESULTS FROM THE SWEDISH PRIMARY CARE CARDIOVASCULAR DATABASE (SPCCD)

B. Wettermark, T. Kahan, K. Manhem, 2015, Journal of Hypertension.

Greater than normal prevalence of seropositivity for Helicobacter pylori among patients who have suffered myocardial infarction

T. Kahan, P. Lundman, G. Olsson, 2000, Coronary artery disease.

The Lifetime Cost Effectiveness of Amlodipine-Based Therapy Plus Atorvastatin Compared with Atenolol Plus Atorvastatin, Amlodipine-Based Therapy Alone and Atenolol-Based Therapy Alone

M. Buxton, N. Poulter, P. Sever, 2012, PharmacoEconomics.

Risk Factors in Established Coronary Heart Disease: Evaluation of a Secondary Prevention Programme

T. Kahan, P. Wändell, 2001, Journal of cardiovascular risk.

A national record linkage to study acute myocardial infarction incidence and case fatality in Sweden.

M Rosén, L Alfredsson, L. Alfredsson, 2001, International journal of epidemiology.

The predictive power of the National Early Warning Score (NEWS) 2, as compared to NEWS, among patients assessed by a Rapid response team: A prospective multi-centre trial

J. Engdahl, T. Djärv, T. Kahan, 2021, Resuscitation plus.

2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).

V. Aboyans, L. Mazzolai, M. Czerny, 2018, Revista espanola de cardiologia.

[2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)]

V. Aboyans, L. Mazzolai, C. Vlachopoulos, 2017, Kardiologia polska.

PP001. The vascular tree during pregnancy and at follow-up - A longitudinal study of maternal vascular function.

T. Kahan, K. Bremme, C. Iacobaeus, 2013, Pregnancy hypertension.

The Effects of Antihypertensive Treatment on the Doppler‐Derived Myocardial Performance Index in Patients with Hypertensive Left Ventricular Hypertrophy: Results from the Swedish Irbesartan in Left Ventricular Hypertrophy Investigation Versus Atenolol (SILVHIA)

L. Lind, J. Ärnlöv, T. Kahan, 2009, Echocardiography.

1 The process of guideline compilation.

L. Mazzolai, G. Mahé, Ali Chraim, 2019, VASA. Zeitschrift fur Gefasskrankheiten.

Confirmed association between neonatal phototherapy or neonatal icterus and risk of childhood asthma

B. Källén, T. Kahan, G. Dahlquist, 2010, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.

Prevalence of treatment-resistant hypertension and important associated factors-results from the Swedish Primary Care Cardiovascular Database.

B. Wettermark, K. Boström, T. Kahan, 2016, Journal of the American Society of Hypertension : JASH.

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Jeroen J. Bax, P. Kirchhof, P. Kolh, 2013, European heart journal.

Non-steroidal anti-inflammatory drugs and blood pressure control in patients treated for hypertension: results from the Swedish primary care cardiovascular database

B. Wettermark, K. Boström, T. Kahan, 2017, Blood pressure.

Adipocyte-derived leucine aminopeptidase genotype and response to antihypertensive therapy

K. Michaëlsson, H. Melhus, L. Lind, 2003, BMC cardiovascular disorders.

Management of a Pregnant Woman With Fibromuscular Dysplasia.

A. Dominiczak, J. Staessen, R. Touyz, 2018, Hypertension.

Guest Editorial Challenges in Resistant Hypertension.

T. Kahan, 2016, European cardiology.